ACUTAAS — Acutaas Chemicals Balance Sheet
0.000.00%
- IN₹134.83bn
- IN₹132.58bn
- IN₹10.07bn
Annual balance sheet for Acutaas Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 26.9 | 996 | 587 | 533 | 2,489 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,210 | 1,693 | 2,675 | 2,792 | 3,484 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,162 | 4,291 | 4,701 | 4,958 | 7,916 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,608 | 1,808 | 2,473 | 4,855 | 6,356 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,133 | 6,589 | 7,669 | 10,959 | 15,493 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,660 | 1,293 | 1,628 | 2,852 | 2,022 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,463 | 1,366 | 1,730 | 4,219 | 2,396 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,669 | 5,223 | 5,940 | 6,740 | 13,096 |
| Total Liabilities & Shareholders' Equity | 4,133 | 6,589 | 7,669 | 10,959 | 15,493 |
| Total Common Shares Outstanding |